HbA1c In-office Point of Service Testing

Policy No: 69
Originally Created: 01/01/2018
Section: Diagnostic
Last Reviewed: 01/01/2019
Last Revised: 01/01/2018
Approved: 01/01/2018
Effective: 01/01/2018


HbA1c in-office point of service testing (D0411)
Simple chair-side screening for dysglycemia via finger-stick random capillary HbA1c glucose testing can be used to rapidly identify high-risk patients. Chair-side screening and appropriate referral may improve diagnosis of pre-diabetes and diabetes.

A code for the finger-stick capillary HbA1c glucose test procedure will assist in broader adoption of this practice in certain dental settings and practices. In addition, it may facilitate further practice-based studies that will assist in demonstrating the acceptability, feasibility, effectiveness of chair-side diabetes screening.


Procedures is in accordance with generally accepted standards of dental practice.

HbA1c in-office point of service testing is not a benefit of the dental contract.

Administrative guidelines

Process to contract benefits.

Procedure is considered medical (deny under dental). Submit on medical claim form with applicable medical CPT code and diagnosis code.


CDT - D0100-D0999 - see above


Your use of this Dental Policy constitutes your agreement to be bound by and comply with the terms and conditions of the Dental Policy Disclaimer.